CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishThe BICRHOME study was a prospective, multicenter study enrolling 312 cirrhotic patients with BSI. In this secondary analysis we selected patients receiving TZP or carbapenems as adequate empiric treatment. The 30-day mortality of patients receiving C/EI or intermittent infusion of TZP or carbapenems was assessed with Kaplan-Meier curves, Cox-regression model and estimation of the average treatment effect (ATE) using propensity score matching.
| Titolo: | Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study | |
| Autore/i: | Bartoletti, Michele; Giannella, Maddalena; Lewis, Russell E; Caraceni, Paolo; Tedeschi, Sara; Paul, Mical; Schramm, Christoph; Bruns, Tony; Merli, Manuela; Cobos-Trigueros, Nazaret; Seminari, Elena; Retamar, Pilar; Muñoz, Patricia; Tumbarello, Mario; Burra, Patrizia; Cerenzia, Maria Torrani; Barsic, Bruno; Calbo, Ester; Maraolo, Alberto Enrico; Petrosillo, Nicola; Galan-Ladero, Maria Angeles; D'Offizi, Gianpiero; Zak-Doron, Yael; Rodriguez-Baño, Jesus; Baldassarre, Maurizio; Verucchi, Gabriella; Domenicali, Marco; Bernardi, Mauro; Viale, Pierluigi | |
| Autore/i Unibo: | ||
| Anno: | 2019 | |
| Rivista: | ||
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1093/cid/ciz032 | |
| Abstract: | The BICRHOME study was a prospective, multicenter study enrolling 312 cirrhotic patients with BSI. In this secondary analysis we selected patients receiving TZP or carbapenems as adequate empiric treatment. The 30-day mortality of patients receiving C/EI or intermittent infusion of TZP or carbapenems was assessed with Kaplan-Meier curves, Cox-regression model and estimation of the average treatment effect (ATE) using propensity score matching. | |
| Data stato definitivo: | 2019-02-27T07:42:13Z | |
| Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
Copyright © 2021